Elghissassi, I., Boutayeb, S., Inrhaoun, H., Mrabti, H., & Errihani, H. (2016). Second-line treatment of non-small-cell lung cancer with wild-type EGFR status. What is the best approach? Curr Oncol.
Styl ChicagoElghissassi, Ibrahim, Saber Boutayeb, Hanane Inrhaoun, Hind Mrabti, a Hassan Errihani. "Second-line Treatment of Non-small-cell Lung Cancer With Wild-type EGFR Status. What Is the Best Approach?" Curr Oncol 2016.
Citace podle MLAElghissassi, Ibrahim, et al. "Second-line Treatment of Non-small-cell Lung Cancer With Wild-type EGFR Status. What Is the Best Approach?" Curr Oncol 2016.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..